Yahoo Finance

Estimated Discount To Fair Value: 23.5%

Vista Group International is trading at NZ$2.97, below its estimated fair value of NZ$3.88, suggesting it may be undervalued based on cash flows. The company is expected to become profitable within three years and achieve earnings growth of 59.87% annually, surpassing the average market growth rate. However, its Return on Equity is forecasted to remain low at 10.8%. Recent investor activism has been resolved with the withdrawal of proposed board changes by Admetus Capital Limited.

• Our growth report here indicates Vista Group International may be poised for an improving outlook.

• Get an in-depth perspective on Vista Group International's balance sheet by reading our health report here.

Beijing Chunlizhengda Medical Instruments

Overview: Beijing Chunlizhengda Medical Instruments Co., Ltd. is an orthopedic medical device company involved in the R&D, production, and trading of surgical implants and instruments in China, with a market cap of approximately HK$5.46 billion.

Operations: The company's revenue segment primarily consists of the manufacture and trading of surgical implants, instruments, and related products, amounting to CN¥924.65 million.

Estimated Discount To Fair Value: 38.2%

Beijing Chunlizhengda Medical Instruments is trading at HK$8.5, below its fair value estimate of HK$13.74, highlighting potential undervaluation based on cash flows. Despite recent declines in revenue and net income for the nine months ending September 2024, earnings are projected to grow significantly at 29.6% annually over the next three years, outpacing the Hong Kong market's growth rate. However, future Return on Equity is expected to be modest at 10.4%.

• Our earnings growth report unveils the potential for significant increases in Beijing Chunlizhengda Medical Instruments' future results.

• Navigate through the intricacies of Beijing Chunlizhengda Medical Instruments with our comprehensive financial health report here.

Taking Advantage

• Investigate our full lineup of 906 Undervalued Stocks Based On Cash Flows right here.

• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.

• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Ready For A Different Approach?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ENXTPA:VU NZSE:VGL and SEHK:1858.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com